The compensation payable in case of transplant failure due to insufficient stem cell count in the umbilical cord blood sample, microbial contamination, and/or inherent sample quality issues, as determined by specialists, **provided that the insurer's responsibility is confirmed**, is as follows:
The compensation payable in case of transplant failure due to insufficient stem cell count in the umbilical cord blood sample, microbial contamination, and/or inherent sample quality issues, as determined by specialists, **provided that the insurer's responsibility is confirmed**, is as follows:
Subject |
Conditions |
Maximum Payable Amount |
In case of diseases of hematopoietic origin
|
In case of **inability to obtain cells** through sources available to the insured
|
2,500,000,000 |
Provided **cells can be obtained** through sources available to the insured
|
500,000,000 |
In case of non-hematopoietic diseases
|
Provided **cells can be obtained** and **cells are not obtained** through sources available to the insured
|
300,000,000 |
In case of diseases of hematopoietic originIn case of **inability to obtain cells** through sources available to the insured 300,000,000 Provided **cells can be obtained** through sources available to the insured
300,000,000
In case of non-hematopoietic diseasesProvided **cells can be obtained** and **cells are not obtained** through sources available to the insured
150,000,000
The amount paid at the time of contract signing + total annual fee up to the time of compensation payment, will be paid.
The amount paid at the time of contract signing + total annual fee up to the time of compensation payment, will be paid.
All umbilical cord blood samples stored at Royan Stem Cell Technology Company are covered against unforeseen events (fire, lightning, explosion). In case of an incident, the amount paid at the time of contract signing + total annual fee up to the time of compensation payment, will be paid.